Grant directory

Open

Supports research teams and institutions for BCRP Breast Cancer Research in biotechnology and medical technology.

Open

Pays tenure-track researchers up to $600,000 to build unproven cancer immunotherapy technology.

Open

Funds translational trauma-care research moving a mature idea toward better survival and care right after injury.

Open

Funds a continuation phase for medical research that already holds earlier DOD or DOW funding, from preclinical work through clinical trials.

Open

Funds early feasibility work on a new orthopaedic treatment or device — the step that comes before any clinical study.

Open

Funds clinical research into combat orthopaedic injury at two levels — one observational, one requiring an actual clinical trial.

Open

Funds a rare-cancer idea that already has some data behind it, ready to move into its next stage of development.

Open

Funds shared rare-cancer research resources — tissue models, datasets or sharing infrastructure — built with named Patient Advocates.

Open

Funds one clinical trial, at any scale, testing what helps a disease or condition linked to military-related toxic exposure.

Open

Funds basic-through-translational research on diseases linked to military-related toxic exposure, at almost any research stage short of a new clinical trial.

Open

Funds translational research turning a promising idea about toxic-exposure illness into a real clinical application.

Open

Funds WARF-disclosed UW Madison inventions through patent and licensing preparation for market-ready transfer.

Open

Funds exploratory studies of the ethical, legal and social consequences of human genetics, especially where a technology or a use of genomic data is new.

Open

Funds a full research project on the ethics, law and social effects of human genetics — and refuses to review an application with no diverse-perspectives plan.

Open

Funds three years replicating a natural product's effect on its target in people, for teams that have already done the pharmacokinetics work.

Open

Funds three years of pharmacokinetics and target-engagement work on a botanical, probiotic or supplement, then three more if the milestones are met.

Open

Funds the mid-phase study that settles a natural product's dose, formulation or responder group before anyone commits to a multi-site efficacy trial.

Open

Funds stroke trials and biomarker studies run inside NIH's national StrokeNet — with its coordinating centres doing recruitment and data.

Open

Supports translational research for FASD prevention and intervention, moving through feasibility and expansion milestones.

Open

Funds the same reanalysis of already-collected cancer data on a smaller, exploratory footing, for teams that do not need a full research project award.

Open

Funds NSF-funded research teams translating discoveries toward field use through industry-aligned pathways and partnerships.

Open

Funding for academic-led development of novel health interventions.

Open

Awards University of Toronto-affiliated early-stage founders up to $15,000 CAD for a three-minute pitch, as part of an annual competition with over $100,000 in total prizes.

Open

Awards University of Toronto-affiliated later-stage founders up to $40,000 CAD for a three-minute pitch, as part of an annual competition with over $100,000 in total prizes.